These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 393518)

  • 1. Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension.
    Tuomilehto J; Nissinen A
    Eur J Clin Pharmacol; 1979; 16(6):369-74. PubMed ID: 393518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between metroprolol, alprenolol and oxprenolol in the treatment of hypertension.
    Tuomilehto J
    Acta Med Scand Suppl; 1979; 625():74-80. PubMed ID: 373397
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
    Comerford MB; Besterman EM
    Ann Clin Res; 1982 Feb; 14(1):27-31. PubMed ID: 7137874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
    Wilcox RG; Hampton JR
    Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
    Turner AS; Watson OF; Brocklehurst JE
    Med J Aust; 1979 Jun; 1(13):625-6. PubMed ID: 386061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoprolol in the long-term treatment of hypertension.
    Comerford MB; Pringle A
    Practitioner; 1976 Dec; 217(1302):953-7. PubMed ID: 796841
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of metoprolol and alprenolol on the metabolic, hormonal, and haemodynamic response to insulin-induced hypoglycaemia in hypertensive, insulin-dependent diabetics.
    Ostman J; Arner P; Haglund K; Juhlin-Dannfelt A; Nowak J; Wennlund A
    Acta Med Scand; 1982; 211(5):381-5. PubMed ID: 7051762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven years on a selective beta-blocker - metoprolol. A long-term study of women with arterial hypertension.
    Bengtsson C
    Ann Clin Res; 1981; 13 Suppl 30():7-15. PubMed ID: 6117244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the antihypertensive effect of a double dose of metoprolol versus the addition of hydrochlorothiazide to metoprolol.
    Smilde JG
    Eur J Clin Pharmacol; 1983; 25(5):581-3. PubMed ID: 6363096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of the hemorrheological pattern in subjects with essential hypertension treated with beta-blocking agents. II. Metoprolol and oxprenolol].
    Caimi G; Frazzetta F; Capobianco D; Catania A; Francavilla G; Sarno A
    Clin Ter; 1982 Nov; 103(4):383-8. PubMed ID: 7151384
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.
    Webster J; Petrie JC; Robb OJ; Jamieson M; Verschueren J
    Br J Clin Pharmacol; 1985 Oct; 20(4):393-400. PubMed ID: 2866786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxprenolol and metoprolol on serum lipid concentration.
    Ferrara LA; Marotta T; Scilla A; Mastranzo P; Strazzullo P; Mancini M
    Eur J Clin Pharmacol; 1984; 26(3):331-4. PubMed ID: 6734694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of metoprolol and reserpine-hydrochlorothiazide.
    Lochaya S; Jansiriskul V; Srivorpongpan R; Jiamsucson K; Suvachittanont O
    J Med Assoc Thai; 1982 Apr; 65(4):203-12. PubMed ID: 7050277
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.
    Davidson C; Thadani U; Singleton W; Taylor SH
    Br Med J; 1976 Jul; 2(6026):7-9. PubMed ID: 7342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of hydrochlorothiazide and a fixed combination of metoprolol and hydrochlorothiazide essential hypertension.
    Dafgärd T; Forsén B; Lindahl T
    Ann Clin Res; 1981; 13 Suppl 30():37-44. PubMed ID: 7027892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.